Retractable Technologies (RVP) Net Equity Issued and Repurchased (2017)
Retractable Technologies (RVP) posted Net Equity Issued and Repurchased of $570100.0 for Q3 2017, down 67.97% on a QoQ basis from $1.8 million in Q1 2017.
Retractable Technologies (RVP) Net Equity Issued and Repurchased (2017) Analysis & Trends
Retractable Technologies' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $570100.0 for Q3 2017.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $570100.0 in Q3 2017, while the trailing twelve-month figure through Dec 2017 was $2.4 million (changed N/A YoY) and the FY2017 annual result came in at $2.4 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was $570100.0 for Q3 2017 at Retractable Technologies, down from $1.8 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $1.8 million in Q1 2017 and bottomed at $570100.0 in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 7.43 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 11.72 Mn |
| 10 | Retractable Technologies | 20.36 Mn | -15.26 Mn | -838,408.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 570,100.00 |
| Sep 30, 2017 | 570,100.00 |
| Mar 31, 2017 | 1.78 Mn |
| Mar 31, 2017 | 1.78 Mn |